Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult
population. Current United States and Canadian Chronic non-cancer pain guidelines …

Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

Objective To assess the efficacy and harms of adding medical cannabis to prescription
opioids among people living with chronic pain. Design Systematic review. Data sources …

Opioids are commonly used to treat patients with chronic pain (CP), though there is little
evidence that they are effective for long term CP treatment. Previous studies reported strong …

Background: Chronic opioid therapy (COT) has been used to treat many chronic pain
conditions even with poor evidence for its long-term effectiveness. Medical cannabis has …

Background The prevalence of opioid-associated morbidity and mortality underscores the
need for research on non-opioid treatments for chronic non-cancer pain (CNCP). Pain is the …

Objective: The opioid epidemic continues to claim thousands of lives every year without an
effective strategy useful in mitigating mortality. The use of medical cannabis has been …

Introduction This phase I open-label study examined pharmacokinetics, safety, and
tolerability of escalating doses of a novel combination cannabinoid medication (1: 1 …

Objective Health care providers are likely to see an increase in the concomitant use of
cannabis and opioids, particularly with the increased liberalization and ongoing research …

Background: There is currently little evidence regarding the use of medical cannabis for the
treatment of intractable pain. Literature published on the subject to date has yielded mixed …